A drug based on that molecule, called Exenatide, became the first approved GLP-1 receptor agonist for treating diabetes in 2005
Diabetic agents, from metformin to SGLT2 inhibitors and GLP1 receptor agonists: JACC focus seminar
So some of the things that I think are really important from this study is that number one, we saw this in individuals who had no CPAP
By keeping an eye on these, doctors can see what needs to change in the treatment plan
19 December 2024: FDA confirms tirzepatide shortage is still over, gives compounders a grace period Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s
The answer is yes, and this combination is often used to improve blood sugar control more than either medication could alone